Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
January 02 2018 - 10:00AM
PR Newswire (US)
BOULDER, Colo., Jan. 2,
2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today
announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P.
Morgan Healthcare Conference in San Francisco. The public is
welcome to participate in the conference through a webcast on the
Array BioPharma website.
|
Event:
|
Annual J.P. Morgan
Healthcare Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer, Array BioPharma
|
|
Date:
|
Monday, January 8,
2018
|
|
Time:
|
4:00 p.m. Pacific
Time
|
|
Location:
|
Westin St. Francis
Hotel, San Francisco
|
|
Webcast:
|
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-calendar
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Nine registration studies are
currently advancing related to seven Array-owned or partnered
drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib
(partnered with AstraZeneca), danoprevir (partnered with Roche),
ipatasertib (partnered with Genentech), larotrectinib (partnered
with Loxo Oncology) and tucatinib (partnered with Cascadian
Therapeutics).
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300574081.html
SOURCE Array BioPharma Inc.
Copyright 2018 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
